Article Information
vol. 3 no. 22
PubMed:
Published By:
History:
- Received May 7, 2017
- Revision received December 4, 2017
- Accepted February 16, 2018
Copyright & Usage:
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works http://www.sciencemag.org/about/science-licenses-journal-article-reuseThis is an article distributed under the terms of the Science Journals Default License.
Author Information
- Héloïse Beutier1,2,3,*,
- Béatrice Hechler4,*,
- Ophélie Godon1,2,
- Yu Wang1,2,5,
- Caitlin M. Gillis1,2,3,
- Luc de Chaisemartin6,7,
- Aurélie Gouel-Chéron1,2,8,
- Stéphanie Magnenat4,
- Lynn E. Macdonald9,
- Andrew J. Murphy9,
- NASA study group†,
- Sylvie Chollet-Martin6,7,
- Dan Longrois8,10,
- Christian Gachet4,
- Pierre Bruhns1,2,‡ and
- Friederike Jönsson1,2,‡
- 1Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France.
- 2INSERM U1222, Paris, France.
- 3Université Pierre et Marie Curie, Paris, France.
- 4Université de Strasbourg, INSERM, Etablissement Français du Sang (EFS) Grand Est, Biologie et Pharmacologie des plaquettes sanguines (BPPS) UMR_S1255, Fédération de Médecine Translationnelle de Strasbourg (FMTS), F-67000 Strasbourg, France.
- 5Université Diderot Paris VII, Paris, France.
- 6Unité Fonctionnelle Auto-immunité et Hypersensibilités, Hôpital Bichat, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris, France.
- 7UMR996—Inflammation, Chemokines et Immunopathology, INSERM, Université Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France.
- 8Département d’Anesthésie-Réanimation, Hôpital Bichat, AP-HP, Paris, France.
- 9Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA.
- 10INSERM UMR1152, Université Paris Diderot Paris 7, Paris, France.
- ↵‡Corresponding author. Email: joensson{at}pasteur.fr (F.J.); bruhns{at}pasteur.fr (P.B.)
↵* These authors contributed equally to this work.
